U.S. Markets closed

Clovis Oncology Inc (CLVS) President and CEO Patrick J Mahaffy Bought $279,500 of Shares

President and CEO of Clovis Oncology Inc (30-Year Financial, Insider Trades) Patrick J Mahaffy (insider trades) bought 50,000 shares of CLVS on 08/16/2019 at an average price of $5.59 a share. The total cost of this purchase was $279,500.

Clovis Oncology Inc is a biopharmaceutical company focused on acquiring, developing and commercializing cancer treatments in the United States, Europe and other international markets. Clovis Oncology Inc has a market cap of $306.077 million; its shares were traded at around $5.60 with and P/S ratio of 2.72. GuruFocus has detected 3 severe warning signs with Clovis Oncology Inc. .

CEO Recent Trades:

  • President and CEO Patrick J Mahaffy bought 50,000 shares of CLVS stock on 08/16/2019 at the average price of $5.59. The price of the stock has increased by 0.18% since.

Directors and Officers Recent Trades:

  • Director Thorlef Spickschen bought 8,600 shares of CLVS stock on 08/16/2019 at the average price of $5.67. The price of the stock has decreased by 1.23% since.
  • Director Thorlef Spickschen bought 9,200 shares of CLVS stock on 08/14/2019 at the average price of $5.46. The price of the stock has increased by 2.56% since.

For the complete insider trading history of CLVS, click here

.This article first appeared on GuruFocus.